Maciej Rupinski
Overview
Explore the profile of Maciej Rupinski including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
28
Citations
1982
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kucha P, Zorniak M, Szmit M, Lipczynski R, Wieszczy-Szczepanik P, Kapala A, et al.
United European Gastroenterol J
. 2023 Nov;
11(10):951-959.
PMID: 37948117
Background: The peroral "pull" technique and the direct "push" procedure are the two main methods for percutaneous endoscopic gastrostomy (PEG) placement. Although pull-PEG is generally recommended as the first-line modality,...
2.
Bretthauer M, Loberg M, Wieszczy P, Kalager M, Emilsson L, Garborg K, et al.
N Engl J Med
. 2022 Oct;
387(17):1547-1556.
PMID: 36214590
Background: Although colonoscopy is widely used as a screening test to detect colorectal cancer, its effect on the risks of colorectal cancer and related death is unclear. Methods: We performed...
3.
Wieszczy P, Bugajski M, Januszewicz W, Rupinska M, Szlak J, Pisera M, et al.
Clin Gastroenterol Hepatol
. 2022 Mar;
21(1):200-209.e6.
PMID: 35341951
Background & Aims: The proportion of colonoscopies with at least one adenoma (adenoma detection rate [ADR]) is inversely associated with colorectal cancer (CRC) risk and death. The aim of this...
4.
Jankowski M, Pietrzak L, Rupinski M, Michalski W, Holdakowska A, Paciorek K, et al.
Radiother Oncol
. 2021 May;
160:229-235.
PMID: 34023328
Background: Frequency and predictive factors for a clinical complete response (cCR) in unselected patients are unclear. Material And Methods: Two prospective observational studies were designed and pooled to explore predictive...
5.
Krzeczewski B, Hassan C, Krzeczewska O, Wieszczy P, Pisera M, Ciopinska-Chaber A, et al.
Pol Arch Intern Med
. 2021 Jan;
131(2):128-135.
PMID: 33491939
Introduction: Colorectal cancer (CRC) is a serious health problem, and various screening programs to reduce CRC have been introduced worldwide. However, the cost‑effectiveness of a program based on once‑in‑a‑lifetime colonoscopy...
6.
Pilonis N, Bugajski M, Wieszczy P, Rupinski M, Pisera M, Pawlak E, et al.
Gastroenterology
. 2020 Dec;
160(4):1097-1105.
PMID: 33307024
Background & Aims: Primary colonoscopy and fecal immunochemical testing (FIT) are considered first-tier tests for colorectal cancer (CRC) screening. Although colonoscopy is considered the most efficacious test, FIT might achieve...
7.
Wieszczy P, Waldmann E, Loberg M, Regula J, Rupinski M, Bugajski M, et al.
Gastroenterology
. 2020 Oct;
160(4):1067-1074.e6.
PMID: 33065063
Background And Aims: Colonoscopy surveillance after adenoma removal is an increasing burden in many countries. Surveillance recommendations consider characteristics of removed adenomas, but not colonoscopist performance. We investigated the impact...
8.
Pilonis N, Bugajski M, Wieszczy P, Franczyk R, Didkowska J, Wojciechowska U, et al.
Ann Intern Med
. 2020 May;
173(2):81-91.
PMID: 32449884
Background: Current guidelines recommend a 10-year interval between screening colonoscopies, but evidence is limited. Objective: To assess the long-term risk for colorectal cancer (CRC) and death from CRC after a...
9.
Wieszczy P, Kaminski M, Franczyk R, Loberg M, Kobiela J, Rupinska M, et al.
Gastroenterology
. 2019 Sep;
158(4):875-883.e5.
PMID: 31563625
Background & Aims: Recommendation of surveillance colonoscopy should be based on risk of colorectal cancer and death after adenoma removal. We aimed to develop a risk classification system based on...
10.
Kobiela J, Spychalski P, Wieszczy P, Pisera M, Pilonis N, Rupinski M, et al.
Clin Gastroenterol Hepatol
. 2019 Sep;
18(7):1501-1508.e3.
PMID: 31525515
Background & Aims: It is difficult to quantify adverse events related to screening colonoscopy due to lack of valid and adequately powered comparison groups. We compared mortality and rate of...